Health informatics

Improving health care in rural areas

With long waiting lists, significant journey times, an ever-shrinking number of doctor's practices and the aging population, medical care services in sparsely populated regions are under mounting pressure. As part of its ...

Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

page 1 from 9